Sutton Wealth Advisors Inc. Abb Vie Inc. Transaction History

Sutton Wealth Advisors Inc.

$203 Billion
Q3 2023

A detailed history of Sutton Wealth Advisors Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Sutton Wealth Advisors Inc. holds 38,197 shares of ABBV stock, worth $7.66 Million. This represents 2.8% of its overall portfolio holdings.

Number of Shares

38,197

Previous 37,807 1.03%

Holding current value

$7.66 Million

Previous $5.09 Billion 11.78%

% of portfolio

2.8%

Previous 2.47%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	BUY	$133.59 - $154.65 $52,100 - $60,313	390 Added 1.03%	38,197 $5.69 Billion
Q2 2023 Nov 08, 2023	SELL	$132.51 - $164.9 $26,634 - $33,144	-201 Reduced 0.53%	37,807 $5.09 Billion
Q1 2023 Nov 07, 2023	SELL	$144.61 - $166.54 $673,593 - $775,743	-4,658 Reduced 10.92%	38,008 $6.06 Billion
Q4 2022 Nov 07, 2023	BUY	$138.31 - $165.87 $14,245 - $17,084	103 Added 0.24%	42,666 $6.9 Billion
Q3 2022 Nov 07, 2023	BUY	$134.21 - $153.93 $117,970 - $135,304	879 Added 2.11%	42,563 $5.71 Billion
Q2 2022 Nov 07, 2023	BUY	$137.62 - $174.96 $116,701 - $148,366	848 Added 2.08%	41,684 $6.38 Billion
Q1 2022 Nov 07, 2023	SELL	$131.98 - $163.75 $75,492 - $93,665	-572 Reduced 1.38%	40,836 $6.62 Billion
Q4 2021 Nov 07, 2023	SELL	$107.43 - $135.93 $3,222 - $4,077	-30 Reduced 0.07%	41,408 $5.61 Billion
Q3 2021 Nov 07, 2023	BUY	$106.4 - $120.78 $55,008 - $62,443	517 Added 1.26%	41,438 $4.47 Billion
Q2 2021 Nov 07, 2023	SELL	$105.21 - $117.21 $8,837 - $9,845	-84 Reduced 0.2%	40,921 $4.61 Billion
Q1 2021 Nov 07, 2023	SELL	$102.3 - $112.62 $84,909 - $93,474	-830 Reduced 1.98%	41,005 $4.44 Billion
Q4 2020 Nov 07, 2023	BUY	$80.49 - $108.67 $12,475 - $16,843	155 Added 0.37%	41,835 $4.48 Billion
Q3 2020 Nov 07, 2023	SELL	$85.91 - $100.83 $97,593 - $114,542	-1,136 Reduced 2.65%	41,680 $3.65 Billion
Q2 2020 Nov 07, 2023	BUY	$73.37 - $98.18 $132,286 - $177,018	1,803 Added 4.4%	42,816 $4.2 Billion
Q1 2020 Nov 07, 2023	BUY	$64.5 - $97.79 $84,301 - $127,811	1,307 Added 3.29%	41,013 $3.12 Billion
Q4 2019 Nov 07, 2023	BUY	$72.13 - $90.25 $3,101 - $3,880	43 Added 0.11%	39,706 $3.52 Billion
Q3 2019 Nov 07, 2023	BUY	$62.98 - $75.72 $12,218 - $14,689	194 Added 0.49%	39,663 $3 Billion
Q2 2019 Nov 06, 2023	BUY	$65.7 - $83.98 $3,285 - $4,199	50 Added 0.13%	39,469 $2.87 Billion
Q1 2019 Nov 06, 2023	BUY	$77.14 - $90.79 $1,774 - $2,088	23 Added 0.06%	39,419 $3.18 Billion
Q4 2018 Nov 06, 2023	BUY	$77.85 - $96.01 $2.67 Million - $3.3 Million	34,330 Added 677.65%	39,396 $3.63 Billion
Q2 2018 Nov 06, 2023	BUY	$89.78 - $106.23 $7,272 - $8,604	81 Added 1.62%	5,066 $469 Million
Q2 2017 Nov 06, 2023	BUY	N/A	13 Added 0.26%	4,985 $361 Million
Q4 2016 Nov 06, 2023	SELL	N/A	-157 Reduced 3.06%	4,972 $311 Million
Q1 2016 Nov 06, 2023	BUY	N/A	5,129	5,129 $293 Million

Others Institutions Holding ABBV

# of Institutions

3,785

Shares Held

1.28B

Call Options Held

13M

Put Options Held

9.82M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $355B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sutton Wealth Advisors Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sutton Wealth Advisors Inc. with notifications on news.

Account

Sutton Wealth Advisors Inc. Abb Vie Inc. Transaction History